Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection
© 2015 Published by Elsevier B.V. Antibody-dependent enhancement (ADE) of dengue virus (DENV) infectivity is thought to play a crucial role in severe dengue disease. It occurs when pre-existing sub-neutralizing anti-DENV antibody (Ab) produced from a primary infection encounters a DENV serotype diff...
Saved in:
Main Authors: | Ririn Ramadhany, Itaru Hirai, Tadahiro Sasaki, Ken Ichiro Ono, Pongrama Ramasoota, Kazuyoshi Ikuta, Takeshi Kurosu |
---|---|
Other Authors: | Osaka University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/36043 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients
by: Panjaporn Chaichana, et al.
Published: (2018) -
Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection
by: Tadahiro Sasaki, et al.
Published: (2018) -
Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus
by: Chonlatip Pipattanaboon, et al.
Published: (2018) -
A highly conserved region between amino acids 221 and 266 of dengue virus non-structural protein 1 Is a major epitope region in infected patients
by: Magot Diata Omokoko, et al.
Published: (2018) -
Limited cross-reactivity of mouse monoclonal antibodies against Dengue virus capsid protein among four serotypes
by: Megumi Noda, et al.
Published: (2018)